A case of type 2 diabetes with a change from a non-dipper to a dipper blood pressure pattern by dapagliflozin

Journal of UOEH

Volumn 38, Issue 2, 2016, Pages 149-153

  Mori, Hiroko ^a   Okada, Yosuke ^a   Kawaguchi, Mayuko ^a   Tanaka, Yoshiya ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

24 hour abpm; Dapagliflozin; Dipper pattern; SGLT2 inhibitors; Type 2 diabetic patient

Indexed keywords

2-(3-(4-ETHOXYBENZYL)-4-CHLOROPHENYL)-6-HYDROXYMETHYLTETRAHYDRO-2H-PYRAN-3,4,5-TRIOL; BENZHYDRYL DERIVATIVE; GLUCOSIDE; SODIUM GLUCOSE COTRANSPORTER;

ANTAGONISTS AND INHIBITORS; BLOOD PRESSURE; CASE REPORT; DRUG EFFECTS; HUMAN; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY;

BENZHYDRYL COMPOUNDS; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; GLUCOSIDES; HUMANS; MALE; MIDDLE AGED; SODIUM-GLUCOSE TRANSPORT PROTEINS;

EID: 84976340181     PISSN: 0387821X     EISSN: None     Source Type: Journal    
DOI: 10.7888/juoeh.38.149     Document Type: Article

References (9)

1. Della Mea P, Lupia M, Bandolin V, Guzzon S, Sonino N, Vettor R & Fallo F (2005): Adiponectin, insulin resistance, and left ventricular structure in dipper and nondipper essential hypertensive patients. Am J Hypertens 18: 30-35
2. Anan F, Takahashi N, Ooie T, Yufu K, Saikawa T & Yoshimatsu H (2003): Role of insulin resistance in nondipper essential hypertensive patients. Hypertens Res 26: 669-676
3. Bailey CJ, Gross JL, Pieters A, Bastien A & List JF (2010): Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial. Lancet 375: 2223-2233
4. Oliva RV & Bakris GL (2014): Blood pressure effects of sodium-glucose co-transport 2 (SGLT2) inhibitors. J Am Soc Hypertens 8: 330-339
5. Lambers Heerspink HJ, de Zeeuw D, Wie L, Leslie B & List J (2013): Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes. Diabetes Obes Metab 15: 853-862
6. Torimoto K, Okada Y, Mori H & Tanaka Y (2013): Relationship between fluctuations in glucose levels measured by continuous glucose monitoring and vascular endothelial dysfunction in type 2 diabetes mellitus. Cardiovasc Diabetol 12: 2-7
7. Ohkubo T, Hozawa A, Yamaguchi J et al (2002): Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens 20: 2183-2189
8. Osorio H, Bautista R, Rios A, Franco M, Arellano A, Vargas-Robles H, Romo E & Escalante B (2010): Effect of phlorizin on SGLT2 expression in the kidney of diabetic rats. J Nephrol 23: 541-546
9. Fujii T, Uzu T, Nishimura M, Takeji M, Kuroda S, Nakamura S, Inenaga T & Kimura G (1999): Circadian rhythm of natriuresis is disturbed in nondipper type of essential hypertension. Am J Kidney Dis 33: 29-35